HER2 overexpression promotes tumour growth by activating MAPK and PI3K/AKT signalling pathways leading to enhanced cell proliferation, invasion and metastasis (Beňačka et al. 2022; Nicolini et al. 2018; Pan et al. 2024). Here, ERBB2 is linked to neoplasm.